“…For inflammatory disorders, targets such as COX-2 (Chaudhary and Aparoy, 2017 ), interleukin 6 (Verma R. et al, 2016 ), toll-like receptors (Shen et al, 2016 ), human leukocyte antigen (Kongkaew et al, 2015 ), chymase enzyme (Verma et al, 2017 ), tumor necrosis factor (Ivanisenko et al, 2014 ), and Nalp3 (Sahoo et al, 2014b ) were studied. For diabetes, analyses of targets included phosphorylase kinase (Begum et al, 2015 ), glycogen synthase kinase (Arfeen et al, 2015 ), protein kinase C beta II (Grewal and Sobhia, 2014 ), and dipeptidyl peptidase-4 enzyme (Gu et al, 2014 ; Sneha and Doss, 2016 ). In a search for compounds for the treatment of chronic kidney disease, Vitamin D receptor and cytochrome P450 were analyzed (Nagamani et al, 2016 ).…”